Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 72162-2194

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 72162-2194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa Chemical Structure (Cls Tabs Carbi Str)

FDA Label Image

Levodopa Chemical Structure (Cls Tabs Levo Str)

Levodopa Chemical Structure (Cls Tabs Levo Str)
Not available.*
FDA Label Image

Label (Lbl721622194)

Label (Lbl721622194)
This text appears to be a description of a medication called "Carbidopa and Levodopa Extended-Release Tablets, USP" which contains 25 mg of Carbidopa and 100 mg of Levodopa. It is advised to keep these tablets out of the reach of children in a tightly closed container at a temperature of 20° to 25°C (68° to 77°F). The tablets should be swallowed whole, without chewing or crushing. The medication is dispensed in a tight, light-resistant container with a child-resistant closure. The text also mentions the NDC code for the tablets, as well as the fact that they are manufactured by Bryant Ranch Prepack, Inc. and relabeled by ScieGen Pharmaceuticals.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.